Bamlanivimab-first EUA approve monoclonal antibody treatment for CoViD19.
Introduction: The first monoclonal antibody drug Bamlanivimab was given an EUA or emergency use authorization by the US FDA last two weeks ago ( November 9, 2020 ) to treat direct SARS-CoV-2 or CoViD19 positive patients with mild to moderate signs and symptoms of the disease. The new antibody treatment was also given to the […]
Clinic Activity Pictures
Recent Comments